Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway

Figure 6

Correlation between S100A16 and pharmacological targets for molecular targeted therapies in the TCGA database. Prediction of KEGG signaling pathway based on GSEA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)